120 related articles for article (PubMed ID: 9612134)
21. Antitumor effects and distribution of adriamycin incorporated into hydroxyapatite implants in a cancer rat model bearing swarm rat chondrosarcoma.
Yamamura K; Iwata H; Osada T; Yotsuyanagi T; Nabeshima T
Jpn J Pharmacol; 1994 Dec; 66(4):433-8. PubMed ID: 7723219
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of Danshen (Salvia miltiorrhiza) on adriamycin-induced cardiac and hepatic toxicity in rats.
You JS; Pan TL; Lee YS
Phytother Res; 2007 Dec; 21(12):1146-52. PubMed ID: 17639557
[TBL] [Abstract][Full Text] [Related]
23. Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver.
Catalá A; Zvara A; Puskás LG; Kitajka K
J Pineal Res; 2007 Jan; 42(1):43-9. PubMed ID: 17198537
[TBL] [Abstract][Full Text] [Related]
24. Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice.
Sadzuka Y; Mochizuki E; Iwazaki A; Hirota S; Takino Y
Biol Pharm Bull; 1995 Jan; 18(1):159-61. PubMed ID: 7735232
[TBL] [Abstract][Full Text] [Related]
25. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect.
Siveski-Iliskovic N; Hill M; Chow DA; Singal PK
Circulation; 1995 Jan; 91(1):10-5. PubMed ID: 7805190
[TBL] [Abstract][Full Text] [Related]
26. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice.
Sazuka Y; Tanizawa H; Takino Y
Jpn J Cancer Res; 1989 Jan; 80(1):89-94. PubMed ID: 2496064
[TBL] [Abstract][Full Text] [Related]
27. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain.
Joshi G; Sultana R; Tangpong J; Cole MP; St Clair DK; Vore M; Estus S; Butterfield DA
Free Radic Res; 2005 Nov; 39(11):1147-54. PubMed ID: 16298740
[TBL] [Abstract][Full Text] [Related]
28. Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
Hassan MH; El-Beshbishy HA; Aly H; Attia SM; Bahashwan SA; Ghobara MM
Cancer Chemother Pharmacol; 2014 Sep; 74(3):559-69. PubMed ID: 25053391
[TBL] [Abstract][Full Text] [Related]
29. Influence of dosing schedule on toxicity and antitumor effects of a combination of adriamycin and docetaxel in mice.
To H; Shin M; Tabuchi M; Sakaguchi H; Takeuchi A; Matsunaga N; Higuchi S; Ohdo S
Clin Cancer Res; 2004 Jan; 10(2):762-9. PubMed ID: 14760099
[TBL] [Abstract][Full Text] [Related]
30. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
31. Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heart.
Satoh M; Naganuma A; Imura N
Toxicology; 1988 Dec; 53(2-3):231-7. PubMed ID: 3212785
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
[TBL] [Abstract][Full Text] [Related]
33. Bepridil enhances adriamycin-induced DNA biosynthesis inhibition in human myeloid leukemia cells.
Parekh H; Advani S; Chitnis M
Sel Cancer Ther; 1990; 6(4):183-91. PubMed ID: 2094938
[TBL] [Abstract][Full Text] [Related]
34. Effect of aclacinomycin on lipid peroxide levels in tissues of mice.
Sazuka Y; Yoshikawa K; Tanizawa H; Takino Y
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3412-5. PubMed ID: 2632090
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline as a modulator of anticancer drug doxorubicin. Part II: Reduction of doxorubicin DNA binding and alleviation of its biological effects.
Gołuński G; Borowik A; Derewońko N; Kawiak A; Rychłowski M; Woziwodzka A; Piosik J
Biochimie; 2016 Apr; 123():95-102. PubMed ID: 26855172
[TBL] [Abstract][Full Text] [Related]
36. Influence of dietary manganese and vitamin E on adriamycin toxicity in mice.
Zidenberg-Cherr S; Keen CL
Toxicol Lett; 1986 Jan; 30(1):79-87. PubMed ID: 3952776
[TBL] [Abstract][Full Text] [Related]
37. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
[TBL] [Abstract][Full Text] [Related]
38. Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin.
Asaum J; Matsuzaki H; Kawasak S; Kuroda M; Takeda Y; Kishi K; Hiraki Y
Anticancer Res; 2000; 20(4):2477-83. PubMed ID: 10953314
[TBL] [Abstract][Full Text] [Related]
39. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
40. Effect of seasonal variation on lipid peroxide level and glutathione peroxidase activity in the mouse before and after adriamycin administration.
Sadzuka Y; Takino Y
Toxicol Lett; 1992 Jun; 61(1):49-56. PubMed ID: 1609438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
